Minto and Eleveld Remifentanil Target Controlled Infusion (TCI) Models: a Clinical Comparison | MicrobiomeTrials← Back to trialsNCT07259291
Minto and Eleveld Remifentanil Target Controlled Infusion (TCI) Models: a Clinical Comparison
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-11-25Est. Completion: 2026-12-30
Enrollment target: 100 participants Locations- ULSS2 Marca Trevigiana, Treviso, Italy
Other microbiome trials you might be interested in
SedationICURemimazolam Besylate
Remimazolam besylate, as a new benzodiazepine drug, showing rapid clearance and moderate distribution of pharmacokinetic…
Guangzhou, ChinaCompleted Dec 31, 2026
FragilityBiliary ObstructionCholangitisMalignancy
This prospective, randomized, single-center study aims to evaluate and compare two different sedation and analgesia regi…
Ankara, Turkey (Türkiye)Est. completion May 30, 2026
Procedural SedationDreams
This randomized clinical trial will evaluate whether music delivered through closed-back headphones during intravenous p…
Multiple LocationsEst. completion Jul 20, 2026